Business · 1 sources covering this

Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas

Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

CNBCLean R·1h ago
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas
Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.
Read at CNBC →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/d9da1dc4186faed47b9601a7fc59a3e8915cc584"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas"></iframe>

Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas

How 1 sources are covering this

Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas

More from Business

Stock futures are little changed after S&P 500 closes at another record: Live updates

CBS News Fires Scott Pelley of ‘60 Minutes’

Macy's posts strongest Q1 growth in four years, raises guidance despite consumer worries

Lloyds, Halifax and Bank of Scotland app users report outage

Reader

Trust & legal

Across the network